Insider Transactions in Q4 2024 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
648
-1.53%
|
-
|
|
Dec 10
2024
|
Emil D Kakkis President & CEO |
SELL
Open market or private sale
|
Indirect |
8,273
-0.38%
|
$413,650
$50.0 P/Share
|
|
Dec 09
2024
|
Emil D Kakkis President & CEO |
SELL
Bona fide gift
|
Indirect |
20,000
-0.9%
|
-
|
|
Oct 10
2024
|
Howard Horn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,465
-7.48%
|
$388,180
$52.76 P/Share
|